NeuroSense Therapeutics NRSN
NASDAQ NRSN
$2.45 -0.11 (-4.87%)
As of: Oct 22, 2026 · 9:59 AM EDT

NeuroSense Therapeutics (NRSN) EPS (Diluted) (2022 - 2024)

Updated

NeuroSense Therapeutics (NRSN) recorded EPS (Diluted) of -$8.73 in FY2025, compared with -$10.98 in FY2024.

Analysis

NeuroSense Therapeutics (NRSN) EPS (Diluted) (2022 - 2024) Analysis & Trends

Starting with FY2020, NeuroSense Therapeutics' EPS (Diluted) history includes 6 years.

  • The FY2025 figure is the highest annual EPS (Diluted) in data going back to FY2020.
  • Per Business Quant data, NRSN's EPS (Diluted) was -$10.98 in FY2024, -$16.23 in FY2023, -$20.25 in FY2022 and -$13.31 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Eli Lilly 1,157.52 Bn 1,126.11 Bn 19.71 Bn 7.94
2 Johnson & Johnson 631.39 Bn 549.92 Bn 17.26 Bn 2.27
3 AbbVie 498.93 Bn 472.04 Bn 12.70 Bn 2.04
4 Merck 376.05 Bn 330.42 Bn 12.21 Bn -0.54
5 Novartis Ag 301.98 Bn 265.97 Bn 11.24 Bn 1.67
6 Astrazeneca 265.05 Bn 238.74 Bn 12.86 Bn 1.60
7 Amgen 240.27 Bn 195.67 Bn 7.24 Bn 4.37
8 Gilead Sciences 193.08 Bn 167.27 Bn 6.22 Bn -8.44
9 Pfizer 171.85 Bn 118.50 Bn 10.94 Bn -0.04
10 NeuroSense Therapeutics 2.74 Mn -1.70 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -1.94
Sep 30, 2024 -3.15
Jun 30, 2024 -1.26
Mar 31, 2024 -7.92
Dec 31, 2023 -4.67
Sep 30, 2023 -0.61
Jun 30, 2023 -6.34
Mar 31, 2023 -5.08
Dec 31, 2022 -2.26
API Access

NeuroSense Therapeutics EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=NRSN&period=max&api_key=YOUR_API_KEY